Search Results 2511-2520 of 20291 for Receptor

1. A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia - Mayo Clinic

   interval. 16. Is receiving a concomitant medication that is known to be a strong CYP3A4 inducer, or a centrally acting histamine 1 (H1) receptor antagonist; ...

2. A Study of AO-176 as Monotherapy Combinated with Bortezomib and Dexamethasone in Adults with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Autologous stem cell transplant, chimeric antigen receptor T-cell treatment, or bone marrow transplant within 12 weeks prior to first dose of study drug.

3. A Clinical Study To Test If An Investigational Treatment Called BNT326 Is Safe And Potentially Beneficial When Used Alone Or In Combination With Other Investigational Treatments Such As BNT327, For People With Advanced Malignant Tumors - Mayo Clinic

   ... receptor (HR)-negative or HR-positive per American Society of Clinical Oncology/College of American Pathologists guidelines. Key Exclusion Criteria ...

4. A Study of Lutetium Lu 177 Dotatate (Lutathera®) in Patients with Inoperable, Progressive Meningioma after External Beam Radiation Therapy - Mayo Clinic

   68Ga-DOTATATE PET imaging must be Krenning score must be a score of 2 or higher, suggesting somatostatin receptor expression, to be enrolled on the study. A ...

5. A Study Of Pirtobrutinib And Brexucabtagene Autoleucel In Relapsed Or Refractory Mantle Cell Lymphoma - Mayo Clinic

   Prior treatment with chimeric antigen receptor (CAR) T-cell therapy. Participants with clinically significant or uncontrolled cardiac disease, including ...

6. Neurology - Clinical trials - Mayo Clinic

   ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...

7. A Study to Determine the Effectiveness and Safety of Luspatercept in Patients with Myelodysplastic/ Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis - Mayo Clinic

   ... receptor activator of nuclear factor kappa-B ligand (RANKL) inhibitors) for their cancer. History of myocardial infarction, stroke, embolism, deep vein or ...

8. New progress in development of gene therapy for arthritis - Mayo Clinic

   A cDNA encoding the interleukin-1 receptor antagonist (IL-1Ra) was delivered to the metacarpophalangeal joints in nine patients with rheumatoid arthritis.

9. A Study to Evaluate Tabelecleucel in Participants With Epstein-barr Virus-associated Diseases - Mayo Clinic

   Within ≤ 8 weeks for cellular therapies (EBV-CTLs, chimeric antigen receptor therapies directed at T cells or T-cell subsets, donor lymphocyte infusion ...

10. A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care Treatments - Mayo Clinic

    ... receptor (CAR) T cells (Note: BCMA antibody-drug conjugates are not excluded) 6. History of progressive multifocal leukoencephalopathy, neurodegenerative ...